Literature DB >> 1956955

Organic nitrate esters: clinical use and mechanisms of actions.

J Ahlner1, R G Andersson, K Torfgård, K L Axelsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1956955

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  34 in total

1.  Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart.

Authors:  G Müller-Strahl; K Kottenberg; H G Zimmer; E Noack; G Kojda
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

Review 2.  Headache-type adverse effects of NO donors: vasodilation and beyond.

Authors:  G Bagdy; P Riba; V Kecskeméti; D Chase; G Juhász
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

Review 3.  A review of chronic anal fissure management.

Authors:  E E Collins; J N Lund
Journal:  Tech Coloproctol       Date:  2007-08-03       Impact factor: 3.781

Review 4.  Mechanisms of action of nitrates.

Authors:  K E Torfgård; J Ahlner
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

Review 5.  Clinical pharmacokinetics of nitrates.

Authors:  M G Bogaert
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

Review 6.  Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Authors:  Daniela Salvemini; Sangwon F Kim; Vincenzo Mollace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

7.  Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.

Authors:  D Salvemini; A Pistelli; E Anggard
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

8.  Various intracellular compartments cooperate in the release of nitric oxide from glycerol trinitrate in liver.

Authors:  Andrey V Kozlov; Barbara Dietrich; Hans Nohl
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

9.  Quercetin and its major metabolites selectively modulate cyclic GMP-dependent relaxations and associated tolerance in pig isolated coronary artery.

Authors:  S Suri; X H Liu; S Rayment; D A Hughes; P A Kroon; P W Needs; M A Taylor; S Tribolo; V G Wilson
Journal:  Br J Pharmacol       Date:  2009-12-24       Impact factor: 8.739

10.  Protection by nicorandil against the dysfunction of the central vagal baroreflex system following transient global cerebral ischaemia in dogs.

Authors:  J Kurihara; N Ochiai; H Kato
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.